Vanguards of Healthcare by Bloomberg Intelligence

Inside Exact Science’s Next Big Bet - One Blood Draw, More than 50 Cancers

This podcast features Jonathan Palmer from Bloomberg Intelligence interviewing Kevin Conroy, CEO of Exact Sciences, a leader in cancer diagnostics. They discuss the evolution of Exact Sciences from its early days to its current status, highlighting key milestones such as the development and launch of Cologuard. The con...

Moon Surgical Connects with Nvidia to Simplify Surgery with AI

Legend Biotech's Race to Make Cell Therapy Mainstream

AKASA's AI Recovers Millions for Health Systems by Simplifying Complexity

From the NIH to ModeX, Dr. Elias Zerhouni on Science, Politics, and Innovation

Zimmer Biomet’s Ivan Tornos is Investing in the Next Chapter of Orthopedics with Arnold

Cognito Can Stimulate Brain Activity with Non-Invasive Gamma Waves

HistoSonics Provides Ultrasound Options to Treat Tumors

Inside GHO Capital’s Thesis on Mid-Market Innovation

Ultromics Can Find Hard-to-Detect Heart Failure with the Power of AI

How the Mark Foundation is Rebuilding the Cancer R&D Model

Inside .406 Ventures’ Vision for Fixing Health Care’s Hardest Problems

How Machinify’s AI Platform Is Rewriting the Rules of Payer Ops

Inside Forbion’s M&A-First Playbook for Building Europe’s Biotech Winners

Rightway’s Plan to Dismantle the Pharmacy Benefit Monopoly

Cleerly Aims to Reinvent Coronary Artery Diagnostics with AI

How AstraZeneca Aims to Stay Ahead in the Race for Oncology Innovation

Overture Aims to Implement Focalplasty as an Early Treatment Option for Osteoarthritis

Lantheus Builds New Foundation in Prostate Cancer, Other Screenings

Sanofi’s R&D Head on AI, Franchises and Reinventing R&D for the Long Game